The new East River Science Park will be built on a city-controlled site on the campus of Bellevue Hospital which the city will lease to Alexandria to develop the largest commercial bioscience
center in New York City.
The Annals and BioScience
both rank among the top five multidisciplinary science periodicals in the authoritative "Journal Citation Reports" study by the Institute for Scientific Information.
The Indianapolis MSA is home to 24,051 bioscience
is a pharmaceutical company specializing in the development and commercialization of products to increase the survival and quality of life for patients with cancer and allied diseases.
(PURE) develops and markets technology-based bioscience
products that provide solutions to numerous global health challenges.
upfront and milestone payments totaling up to $10 million as regulatory and pricing approvals are obtained.
Krall, President and CEO of PURE Bioscience
, said, "We always enjoy the opportunity to meet fellow shareholders, and we look forward to providing an update on the progress and status of our business.
with a means of developing and marketing our products in Japan, but also provides a potential base from which the company can establish its own presence in this important market," said Philip S.
In conjunction with the financing, Carol Marino, Vice President, Venture Investments, Johnson & Johnson Development Corporation joins the Phase Bioscience
Board of Directors.
, 215-832-4503; or Charles Versaggi of Versaggi & Associates, 408-358-4162 or 408-395-1877, for U.
A critical element of this project is raising the visibility of Ohio's bioscience
assets," said Omeris President & CEO Tony Dennis.
With the development of over 200 new assays scheduled in the next 18 months, Multiplex Bioscience
is a strategically important addition to Rules-Based Medicine," said Craig Benson, President and CEO of Rules-Based Medicine.
SAN DIEGO -- PURE Bioscience
(OTCBB:PURE), developer, manufacturer and marketer of technology-based bioscience
products providing non-toxic antimicrobial solutions, announced today that it will present at the Rodman & Renshaw Healthcare Conference on Monday, November 6th at the New York Palace Hotel.
COLUMBUS, Ohio -- Omeris, Ohio's bioscience
membership and development organization, will host "BioOhio 2006: Building the Bioscience
Workforce" on October 23 and 24 at the Hilton Columbus.
DRESDEN, Germany -- Cenix BioScience
GmbH (Dresden), the leading specialist in advanced RNA interference (RNAi)-based research services, and Merck KGaA (Darmstadt, Germany), a leading global pharmaceutical company, today announced that they have signed a framework research agreement securing Cenix services to enhance and accelerate Merck target discovery and validation efforts in oncology, with an option to expand in several human disease programs.